Diagnostic capability of 18F-PSMA PET-MRI and pelvic MRI plus bone scan in treatment-naive prostate cancer: a single-center paired validating confirmatory study
Ziyun Qiao(Shanghai East Hospital), Haifeng Wang, Jun Zhao(Shanghai East Hospital), Qiwei Yang(Shanghai East Hospital), Shuaidong Wang(Shanghai East Hospital), Haiyan Wang(Hebei Medical University), Xing Chen(Nantong University), Hai Zhou(Yuncheng University), Zhenkai Shi(Shanghai East Hospital), Zhiwen You(Shihezi University), Biming He(Shanghai East Hospital)
Cited by 6
Related Papers
TMEM16A Induces MAPK and Contributes Directly to Tumorigenesis and Cancer Progression
|Cancer Research|2012|289
Ubiquitylation of Autophagy Receptor Optineurin by HACE1 Activates Selective Autophagy for Tumor Suppression
|Cancer Cell|2014|249
Comparative Evaluation of Participation and Diagnostic Yield of Colonoscopy vs Fecal Immunochemical Test vs Risk-Adapted Screening in Colorectal Cancer Screening: Interim Analysis of a Multicenter Randomized Controlled Trial (TARGET-C)
|The American Journal of Gastroenterology|2020|78
miR‐152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines
|The Prostate|2013|76
miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells
|Molecular and Cellular Biochemistry|2013|69